查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1876472

全球骨髓移植市场：产业分析、规模、份额、成长、趋势和预测（2025-2032）

Bone marrow transplantation market Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 190 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research近期发布了一份关于全球骨髓移植市场的综合报告。该报告详细分析了关键市场趋势，包括市场驱动因素、新兴趋势、机会和挑战。报告深入剖析了市场格局，相信能够帮助相关人员做出明智的决策。

主要发现：

  • 骨髓移植市场规模（2025年）：116亿美元
  • 预计市场价值（2032年）：157亿美元
  • 全球市场成长率（2025年至2032年复合年增长率）：4.5%

骨髓移植市场研究范围：

骨髓移植市场涵盖以健康干细胞取代受损或坏死骨髓的医疗程序，广泛用于治疗血液疾病和免疫力缺乏。白血病和淋巴瘤等癌症发生率的不断上升，以及细胞疗法和移植技术的进步，正显着推动全球对骨髓移植的需求。公众意识的提高、支持性的法规结构以及完善的捐赠者登记系统也进一步促进了市场成长。

市场成长驱动因素：

全球骨髓移植市场正稳定成长，主要驱动因素是白血病、淋巴瘤和多发性骨髓瘤等骨髓恶性肿瘤发生率的上升。干细胞采集和移植技术的进步提高了患者的治疗效果和安全性，促进了该技术的广泛应用。医疗基础设施投资的增加和专业移植中心的扩建，尤其是在新兴经济体，也推动了市场成长。此外，各国政府和非营利组织为促进捐赠者登记和提高公众对干细胞捐赠的认识所做的努力，也支撑了全球对骨髓移植的需求。

市场限制：

儘管前景乐观，骨髓移植市场仍面临诸多限制。治疗费用高和移植手术复杂是主要障碍，尤其是在中低收入国家。寻找匹配供体，特别是异基因移植供体，仍然是一项持续存在的挑战。此外，移植后併发症（例如移植物抗宿主疾病）和高感染疾病风险会影响患者存活率，并阻碍移植手术的进行。另外，干细胞研究和捐赠行为的监管障碍和伦理问题也可能在某些地区阻碍市场扩张。

市场机会：

骨髓移植市场蕴藏着巨大的发展机会，主要得益于再生医学和细胞疗法的研发。单倍体相合移植和脐带血移植的发展，使得那些没有完全匹配捐赠者的患者也能获得移植机会。学术机构与生技公司之间日益紧密的合作，推动了移植技术和移植后护理的创新。拓展至南亚、拉丁美洲和非洲部分地区等尚未开发的市场，为市场提供了巨大的成长潜力，这些地区对先进癌症治疗的需求正在增长。此外，数位健康平台和人工智慧驱动的供体匹配系统预计将在未来几年内提​​升移植的成功率和效率。

本报告解答的关键问题：

  • 推动全球骨髓移植市场成长的关键因素有哪些？
  • 哪种移植类型和疾病适应症占据最大的市场份额？
  • 科技创新如何影响移植手术和患者照护？
  • 骨髓移植市场的主要参与者有哪些？他们的战略重点是什么？
  • 新兴地区和专科护理领域有哪些成长机会？

目录

第一章执行摘要

第二章 市场概览

  • 市场范围和定义
  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 主要趋势
  • 新冠疫情影响分析
  • 预测因子－相关性和影响

第三章 加值见解

  • 服务招募分析
  • 移植成本分析
  • 价值链分析
  • 疾病流行病学
  • 监管状态
  • PESTLE分析

第四章：全球骨髓移植市场展望

  • 主要亮点
    • 市场规模和年成长率
    • 绝对商机
  • 市场规模分析与预测
    • 市场规模绩效分析，2019-2024年
    • 市场规模分析及预测（2025-2032年）
  • 全球骨髓移植市场展望：移植类型
    • 按移植类型分類的市场规模绩效分析，2019-2024 年
    • 按移植类型分類的市场规模分析与预测（2025-2032 年）
      • 自体骨髓移植
      • 异基因骨髓移植
      • 同基因移植
    • 市场吸引力分析：移植类型
  • 全球骨髓移植市场展望：适应症
    • 依适应症分類的市场规模表现分析，2019-2024 年
    • 按适应症分類的市场规模分析与预测（2025-2032 年）
      • 白血病
      • 淋巴瘤
      • 多发性骨髓瘤
      • 再生障碍性贫血
      • 镰状细胞贫血症
      • 其他的
    • 市场吸引力分析：指标
  • 全球骨髓移植市场展望：终端用户
    • 按最终用户分類的市场规模绩效分析，2019-2024 年
    • 依最终用户分類的市场规模分析及预测（2025-2032 年）
      • 医院
      • 多学科诊所
      • 门诊手术中心
      • 癌症研究所
    • 市场吸引力分析：最终用户

5. 全球骨髓移植市场区域展望

  • 2019-2024年各地区市场规模表现分析
  • 市场规模分析及预测（依地区划分，2025-2032年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：区域

第六章 北美骨髓移植市场展望

7. 欧洲骨髓移植市场展望

第八章 东亚骨髓移植市场展望

第九章 南亚和大洋洲骨髓移植市场展望：

第十章 拉丁美洲骨髓移植市场展望：

第十一章 中东与非洲骨髓移植市场展望：

第十二章附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP4288

Persistence Market Research has recently released a comprehensive report on the global Bone Marrow Transplantation Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Bone Marrow Transplantation Market Size (2025E): US$ 11.6 Bn
  • Projected Market Value (2032F): US$ 15.7 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.5%

Bone Marrow Transplantation Market - Report Scope:

The bone marrow transplantation market encompasses medical procedures used to replace damaged or destroyed bone marrow with healthy stem cells, widely utilized in the treatment of hematologic diseases and immune deficiencies. The increasing prevalence of cancers such as leukemia and lymphoma, coupled with advancements in cell therapy and transplant techniques, has significantly fueled the demand for bone marrow transplants globally. Rising awareness, supportive regulatory frameworks, and improvements in donor registries further enhance market growth.

Market Growth Drivers:

The global bone marrow transplantation market is witnessing steady growth, primarily driven by the rising incidence of hematologic malignancies such as leukemia, lymphoma, and multiple myeloma. Technological advancements in stem cell harvesting and transplantation techniques have improved patient outcomes and safety, thereby encouraging wider adoption. Increased investments in healthcare infrastructure and the expansion of specialized transplant centers, particularly in emerging economies, are contributing to market growth. Furthermore, initiatives by governments and non-profit organizations to increase donor registration and public awareness about stem cell donation are supporting the global demand for bone marrow transplantation.

Market Restraints:

Despite the positive outlook, the bone marrow transplantation market faces several restraints. High treatment costs and the complexity of transplant procedures pose significant barriers, particularly in low- and middle-income countries. Limited availability of compatible donors, especially for allogeneic transplants, remains a persistent challenge. Moreover, post-transplant complications, such as graft-versus-host disease (GVHD), and the high risk of infections continue to impact patient survival and deter some from pursuing transplantation. In addition, regulatory hurdles and ethical concerns surrounding stem cell research and donor practices may hamper market expansion in certain regions.

Market Opportunities:

The market for bone marrow transplantation holds promising opportunities driven by the increasing research in regenerative medicine and cellular therapies. The development of haploidentical and cord blood transplants has broadened the scope for patients lacking fully matched donors. Growing collaborations between academic institutions and biotechnology companies are fostering innovation in transplant techniques and post-transplant care. Expansion into untapped regions such as South Asia, Latin America, and parts of Africa, where the demand for advanced cancer treatment is rising, offers substantial growth prospects. Moreover, digital health platforms and AI-driven donor matching systems are expected to improve transplant success rates and efficiency in the coming years.

Key Questions Answered in the Report:

  • What are the primary factors driving the global bone marrow transplantation market's growth?
  • Which transplant types and disease indications account for the largest market share?
  • How are technological innovations influencing transplant procedures and patient care?
  • Who are the key players in the bone marrow transplantation market, and what are their strategic priorities?
  • What are the growth opportunities in emerging regions and specialized healthcare segments?

Competitive Intelligence and Business Strategy:

Leading companies in the global bone marrow transplantation market, such as Lonza Group Ltd., Merck Millipore Corporation, and Sanofi-Aventis LLC, are focusing on research and development of advanced stem cell products and transplant solutions. Firms like STEMCELL Technologies and ATCC Inc. are strengthening their offerings in cell processing and cryopreservation tools. Companies such as ReeLabs Pvt. Ltd. and HemaCare are emphasizing strategic collaborations with hospitals and cancer research institutes to improve access to donor registries and transplant services. Investment in infrastructure, development of cost-effective transplant kits, and geographic expansion remain central to competitive strategies in this market.

Companies Covered in This Report:

  • Lonza Group Ltd.
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC
  • STEMCELL Technologies
  • American Type Culture Collection (ATCC) Inc.
  • ReeLabs Pvt. Ltd.
  • HemaCare

Market Segmentation:

By Type of Transplant

  • Autologous Bone Marrow Transplantation
  • Allogeneic Bone Marrow Transplantation
  • Syngeneic Transplantation

By Indication

  • Leukemia
  • Lymphoma
  • Myeloma
  • Aplastic Anemia
  • Sickle Cell Anemia
  • Others

By End-user

  • Hospitals
  • Multispecialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institute

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Bone Marrow Transplantation Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. COVID-19 Impact Analysis
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Service Adoption Analysis
  • 3.2. Transplant Cost Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Disease Epidemiology
  • 3.5. Regulatory Landscape
  • 3.6. PESTLE Analysis

4. Global Bone Marrow Transplantation Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Bone Marrow Transplantation Market Outlook: Type of Transplant
    • 4.3.1. Historical Market Size (US$ Bn) Analysis, By Type of Transplant, 2019-2024
    • 4.3.2. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
      • 4.3.2.1. Autologous Bone Marrow Transplantation
      • 4.3.2.2. Allogeneic Bone Marrow Transplantation
      • 4.3.2.3. Syngeneic Transplantation
    • 4.3.3. Market Attractiveness Analysis: Type of Transplant
  • 4.4. Global Bone Marrow Transplantation Market Outlook: Indication
    • 4.4.1. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2024
    • 4.4.2. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
      • 4.4.2.1. Leukemia
      • 4.4.2.2. Lymphoma
      • 4.4.2.3. Myeloma
      • 4.4.2.4. Aplastic Anemia
      • 4.4.2.5. Sickle Cell Anemia
      • 4.4.2.6. Others
    • 4.4.3. Market Attractiveness Analysis: Indication
  • 4.5. Global Bone Marrow Transplantation Market Outlook: End User
    • 4.5.1. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
    • 4.5.2. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.2.1. Hospitals
      • 4.5.2.2. Multispecialty Clinics
      • 4.5.2.3. Ambulatory Surgical Centers
      • 4.5.2.4. Cancer Research Institutes
    • 4.5.3. Market Attractiveness Analysis: End User

5. Global Bone Marrow Transplantation Market Outlook: Region

  • 5.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.2.1. North America
    • 5.2.2. Europe
    • 5.2.3. East Asia
    • 5.2.4. South Asia and Oceania
    • 5.2.5. Latin America
    • 5.2.6. Middle East & Africa
  • 5.3. Market Attractiveness Analysis: Region

6. North America Bone Marrow Transplantation Market Outlook

  • 6.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.1.1. By Country
    • 6.1.2. By Type of Transplant
    • 6.1.3. By Indication
    • 6.1.4. By End User
  • 6.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 6.3.1. Autologous Bone Marrow Transplantation
    • 6.3.2. Allogeneic Bone Marrow Transplantation
    • 6.3.3. Syngeneic Transplantation
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 6.4.1. Leukemia
    • 6.4.2. Lymphoma
    • 6.4.3. Myeloma
    • 6.4.4. Aplastic Anemia
    • 6.4.5. Sickle Cell Anemia
    • 6.4.6. Others
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 6.5.1. Hospitals
    • 6.5.2. Multispecialty Clinics
    • 6.5.3. Ambulatory Surgical Centers
    • 6.5.4. Cancer Research Institutes
  • 6.6. Market Attractiveness Analysis

7. Europe Bone Marrow Transplantation Market Outlook

  • 7.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.1.1. By Country
    • 7.1.2. By Type of Transplant
    • 7.1.3. By Indication
    • 7.1.4. By End User
  • 7.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. U.K.
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Russia
    • 7.2.7. Rest of Europe
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 7.3.1. Autologous Bone Marrow Transplantation
    • 7.3.2. Allogeneic Bone Marrow Transplantation
    • 7.3.3. Syngeneic Transplantation
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 7.4.1. Leukemia
    • 7.4.2. Lymphoma
    • 7.4.3. Myeloma
    • 7.4.4. Aplastic Anemia
    • 7.4.5. Sickle Cell Anemia
    • 7.4.6. Others
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.5.1. Hospitals
    • 7.5.2. Multispecialty Clinics
    • 7.5.3. Ambulatory Surgical Centers
    • 7.5.4. Cancer Research Institutes
  • 7.6. Market Attractiveness Analysis

8. East Asia Bone Marrow Transplantation Market Outlook:

  • 8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.1.1. By Country
    • 8.1.2. By Type of Transplant
    • 8.1.3. By Indication
    • 8.1.4. By End User
  • 8.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.2.1. China
    • 8.2.2. Japan
    • 8.2.3. South Korea
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 8.3.1. Autologous Bone Marrow Transplantation
    • 8.3.2. Allogeneic Bone Marrow Transplantation
    • 8.3.3. Syngeneic Transplantation
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 8.4.1. Leukemia
    • 8.4.2. Lymphoma
    • 8.4.3. Myeloma
    • 8.4.4. Aplastic Anemia
    • 8.4.5. Sickle Cell Anemia
    • 8.4.6. Others
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.5.1. Hospitals
    • 8.5.2. Multispecialty Clinics
    • 8.5.3. Ambulatory Surgical Centers
    • 8.5.4. Cancer Research Institutes
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Bone Marrow Transplantation Market Outlook:

  • 9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.1.1. By Country
    • 9.1.2. By Type of Transplant
    • 9.1.3. By Indication
    • 9.1.4. By End User
  • 9.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.2.1. India
    • 9.2.2. Southeast Asia
    • 9.2.3. ANZ
    • 9.2.4. Rest of South Asia & Oceania
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 9.3.1. Autologous Bone Marrow Transplantation
    • 9.3.2. Allogeneic Bone Marrow Transplantation
    • 9.3.3. Syngeneic Transplantation
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 9.4.1. Leukemia
    • 9.4.2. Lymphoma
    • 9.4.3. Myeloma
    • 9.4.4. Aplastic Anemia
    • 9.4.5. Sickle Cell Anemia
    • 9.4.6. Others
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.5.1. Hospitals
    • 9.5.2. Multispecialty Clinics
    • 9.5.3. Ambulatory Surgical Centers
    • 9.5.4. Cancer Research Institutes
  • 9.6. Market Attractiveness Analysis

10. Latin America Bone Marrow Transplantation Market Outlook:

  • 10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.1.1. By Country
    • 10.1.2. By Type of Transplant
    • 10.1.3. By Indication
    • 10.1.4. By End User
  • 10.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 10.3.1. Autologous Bone Marrow Transplantation
    • 10.3.2. Allogeneic Bone Marrow Transplantation
    • 10.3.3. Syngeneic Transplantation
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 10.4.1. Leukemia
    • 10.4.2. Lymphoma
    • 10.4.3. Myeloma
    • 10.4.4. Aplastic Anemia
    • 10.4.5. Sickle Cell Anemia
    • 10.4.6. Others
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.5.1. Hospitals
    • 10.5.2. Multispecialty Clinics
    • 10.5.3. Ambulatory Surgical Centers
    • 10.5.4. Cancer Research Institutes
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Bone Marrow Transplantation Market Outlook:

  • 11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.1.1. By Country
    • 11.1.2. By Type of Transplant
    • 11.1.3. By Indication
    • 11.1.4. By End User
  • 11.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.2.1. GCC Countries
    • 11.2.2. Egypt
    • 11.2.3. South Africa
    • 11.2.4. Northern Africa
    • 11.2.5. Rest of Middle East & Africa
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 11.3.1. Autologous Bone Marrow Transplantation
    • 11.3.2. Allogeneic Bone Marrow Transplantation
    • 11.3.3. Syngeneic Transplantation
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 11.4.1. Leukemia
    • 11.4.2. Lymphoma
    • 11.4.3. Myeloma
    • 11.4.4. Aplastic Anemia
    • 11.4.5. Sickle Cell Anemia
    • 11.4.6. Others
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.5.1. Hospitals
    • 11.5.2. Multispecialty Clinics
    • 11.5.3. Ambulatory Surgical Centers
    • 11.5.4. Cancer Research Institutes
  • 11.6. Market Attractiveness Analysis

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations